Commonwealth Biotechnologies, Inc. Announces Appointment of Senior Vice President, Sales, Marketing, and Business Development; Joseph Chimera, Ph.D. Will Bring Extensive Experience in the Life Sciences Business Development Arena.RICHMOND, Va. -- Commonwealth Biotechnologies, Inc. (CBI CBI abbr. cumulative book index CBI Confederation of British Industry CBI n abbr (= Confederation of British Industry) → C.E.O.E. ) (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CBTE), today announced that Dr. Joseph Chimera will be joining the company as Senior Vice President, Sales, Marketing, and Business Development. Dr. Chimera brings over 20 years experience in the life sciences services area which has been built upon outstanding graduate and post-graduate training in modern molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller . More specifically, he brings an extensive background in genomics, clinical testing, and, most recently, informatics. He has been responsible for planning, launch, and management of several new business units in his previous positions and will be specifically charged with growing the commercial client base of CBI. Dr. Chimera will assume immediate oversight of CBI's sales, marketing, and business development activities. "While CBI has established itself as a solid player in the government contracting arena, we have lagged in growing the commercial sector. Growth in the commercial sector is not only important for revenue growth in general but also for revenue balance between government and commercial clients and for the better margins achievable in the commercial sector. Dr. Chimera brings a unique mix of solid science and business development skills that will allow him to interface very effectively with both those responsible for product development and for pipeline management in the Pharma and Biotech clients we seek," said Richard J. Freer, Ph.D., Chairman and COO of CBI. "This is an outstanding new appointment for us and we are looking forward to Joe joining the management team at CBI," he added. "Joe lead expansion initiatives at a previous employer which transformed an $8 million sales program into a $24 million discrete business unit," added Robert B. Harris, Ph.D., President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of CBI. "He has helped develop and otherwise manage commercialization strategies for life-sciences related services. We are looking for Looking for In the context of general equities, this describing a buy interest in which a dealer is asked to offer stock, often involving a capital commitment. Antithesis of in touch with. Joe to bring the same measured levels of success to CBI that he brought to his former positions." "CBI's core competencies can provide solutions to a broad range of commercial markets, including discovery research, companies focused on developing new therapeutics and suppliers of diagnostics tests and laboratory services. Our commercialization strategy will initially focus on short-term revenue growth by leveraging existing commercial customer relationships. Longer-term, we will focus on attracting customers from diverse markets within the life sciences research and development and healthcare industries," said Dr. Chimera. About CBI Commonwealth Biotechnologies, Inc. is a solutions provider to the global biotechnology industry, academic institutions, government agencies, and pharmaceutical companies. It offers broad ranging expertise and a complete array of the most current analytical and synthetic chemistries and biophysical analysis technologies, many of which are not available from other commercial sources. CBI has crafted a stimulating, open environment where scientists collaborate among themselves and with our clients, take on interesting challenges and develop creative solutions. Through its FIL division, CBI offers comprehensive genetic identity testing, including paternity The state or condition of a father; the relationship of a father. English and U.S. Common Law have recognized the importance of establishing the paternity of children. , forensic, and CODIS CODIS Combined DNA Index System (US FBI) CODIS Convicted Offender DNA Index System CODIS Component and Distributed Systems analyses. CBI is accredited accredited recognition by an appropriate authority that the performance of a particular institution has satisfied a prestated set of criteria. accredited herds cattle herds which have achieved a low level of reactors to, e.g. by the American Association American Association refers to one of the following professional baseball leagues:
Sometimes called simply forensics, forensic science encompasses many different fields of science, including anthropology, biology, chemistry, engineering, genetics, Technology Council, and operates fully accredited BSL-3 laboratory. For more information, visit CBI on the web at www.cbi-biotech.com and visit FIL at www.fairfaxidlab.com. Any statements contained in this release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties as identified in the Company's filings with the Securities and Exchange Commission. Specifically, there can be no assurances that new revenues will be generated as a result of enhanced marketing efforts. Actual results, events or performance may differ materially. No statement herein should be considered an offer of any securities. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion